
|Videos|April 26, 2022
ViaLase shares updates on new technology to treat glaucoma, company updates and upcoming trials
Author(s)Kassi Filkins
Tom Frinzi, executive chairman of ViaLase, a new company based in Orange County, gives an update on the company, sharing some exciting new things happening.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Tinlarebant NDA submission completed for Stargardt disease type 1, targeting first approved therapy
2
FDA accepts Outlook Therapeutics' resubmitted BLA for ONS-5010 (LYTENAVA)
3
Expanding the ICRS toolkit: Keraring for high regular astigmatism
4
DSLT for glaucoma and ocular hypertension: Real-world outcomes in 218 eyes
5





















